As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the ...

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which ...

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need ...

The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...